Lloyd Mitchell Segal is PRESIDENT AND CEO of Repare Therapeutics Inc.. Currently has a direct ownership of 124,677 shares of RPTX, which is worth approximately $168,313. The most recent transaction as insider was on Mar 01, 2024, when has been sold 40,000 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 125K
0% 3M change
47.24% 12M change
Total Value Held $168,313

Lloyd Mitchell Segal Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 01 2024
BUY
Grant, award, or other acquisition
-
40,000 Added 24.29%
124,677 Common Shares
Jan 30 2023
BUY
Grant, award, or other acquisition
-
78,550 Added 48.12%
84,677 Common Shares
Jun 04 2021
SELL
Open market or private sale
$156,250 $31.25 p/Share
5,000 Reduced 50.0%
5,000 Common Stock
Jun 04 2021
BUY
Exercise of conversion of derivative security
$8,200 $1.64 p/Share
5,000 Added 33.33%
10,000 Common Stock
LMS

Lloyd Mitchell Segal

PRESIDENT AND CEO
St Laurent, A8

Track Institutional and Insider Activities on RPTX

Follow Repare Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPTX shares.

Notify only if

Insider Trading

Get notified when an Repare Therapeutics Inc. insider buys or sells RPTX shares.

Notify only if

News

Receive news related to Repare Therapeutics Inc.

Track Activities on RPTX